Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Health and Quality of Life Outcomes
Published in: Health and Quality of Life Outcomes 1/2012

Open Access 01-12-2012 | Research

Health-related quality of life in different clinical subgroups with typical AFL who have undergone cavo-tricuspid isthmus ablation

Authors: Javier García Seara, Francisco Gude, Pilar Cabanas, José L Martínez-Sande, Xesús Fernández López, Antonio Hernández Madrid, Concepción Moro, José González Juanatey R

Published in: Health and Quality of Life Outcomes | Issue 1/2012

Login to get access

Abstract

Background

To evaluate changes in health-related quality of life (HRQOL) in different sub-groups of a cohort of patients with typical atrial flutter (AFL) treated with cavotricuspid isthmus (CTI) radiofrequency catheter ablation.

Methods

95 consecutive patients due to undergo CTI ablation were enrolled in a study involving their completion of two SF-36 HRQOL questionnaires, before ablation and at one-year follow-up.

Results

88 of the initial 95 patients finished the study. Regardless of whether patients experienced atrial fibrillation (AF) during follow-up, a statistically significant improvement in HRQOL was observed, compared with pre-ablation scores and in all dimensions except Bodily Pain. However, patients without AF during follow-up had significantly higher absolute HRQOL scores in most dimensions. No differences were seen in most HRQOL dimensions, with respect to AFL type (paroxysmal, persistent) or duration, whether AFL was first-episode or recurrent, Class I-III drug dependent, sex, or presence of structural heart disease or tachycardiomyopathy. Patients with persistent AFL showed the greatest improvement in HRQOL when they also had a ventricular cycle length ≤500 ms. The combination of recurrent AFL, ventricular cycle length ≤500 ms and structural heart disease led to a significantly greater improvement in physical HRQOL dimensions than did first-episode AFL, no structural heart disease and ventricular cycle >500 ms. The only independent factor associated with a greater improvement was structural cardiopathy.

Conclusions

CTI-ablation treatment leads to a significant improvement in HRQOL in patients with typical AFL. Patients with AF during follow-up show a significantly lower HRQOL at one-year post-ablation. The only independent risk factor found to be associated with a greater improvement in the physical summary component was structural cardiopathy.
Appendix
Available only for authorised users
Literature
1.
Saoudi N, Cosío F, Waldo A, Chen S, Iesaka Y, Lesh M, Saksena S, et al.: Working group of Arrhythmias of the European of Cardiology and the North American Society of Pacing and Electrophysiology. A classification of atrial flutter and regular atrial tachycardia according to electrophysiological mechanisms and anatomical bases. Eur Heart J 2001, 22: 1162–1182. 10.1053/euhj.2001.2658CrossRefPubMed
2.
García-Cosío F, Pastor A, Núñez A, Magalhaes A, Awamleh P: Flúter auricular: perspectiva clínica actual. Rev Esp Cardiol 2006, 59: 816–831. 10.1157/13091886CrossRefPubMed
3.
Feld GK, Fleck RP, Chen PS, Boyce K, Bahnson TD, Stein JB, Calisi CM, et al.: Radiofrequency catheter ablation for the treatment of human type I atrial flutter. Identification of a critical zone in the reentrant circuit by endocardial mapping techniques. Circulation 1992, 86: 1233–1240. 10.1161/01.CIR.86.4.1233CrossRefPubMed
4.
Cosío FG, Arribas F, López-Gil M, Palacios J: Atrial flutter mapping and ablation. I. Atrial flutter mapping. Pacing Clin Electrophysiol 1996, 19: 841–853. 10.1111/j.1540-8159.1996.tb03368.xCrossRefPubMed
5.
Calkins H, Canby R, Weiss R, Taylor G, Wells P, Chinitz L, Milstein S, et al.: 100 W Atakr II Investigator Group. Results of catheter ablation of typical atrial flutter. Am J Cardiol 2004, 94: 437–442. 10.1016/j.amjcard.2004.04.058CrossRefPubMed
6.
Feld GK, Wharton M, Pluma V, Daoud E, Friehling T, Epstein L: for the EPT-100 XP Cardiac Ablation System Investigators. Radiofrequency catheter ablation of type 1 atrial flutter using large-tip 8 - or 10-mm electrode catheters and a high – output radiofrequency energy generator. Results of a multicenter safety and efficacy study. J Am Coll Cardiol 2004, 43: 1466–1472. 10.1016/j.jacc.2003.11.036CrossRefPubMed
7.
O´Callaghan PA, Meara M, Kongsgaard E, Poloniecki J, Luddington L, Foran J, Camm AJ, et al.: Symptomatic improvement after radiofrequency catheter ablation for typical atrial flutter. Heart 2001, 86: 167–171. 10.1136/heart.86.2.167CrossRef
8.
Lee SH, Tai CT, Yu WC, Chen YJ, Hsieh MH, Tsai CF, Chang MS, et al.: Effects of radiofrequency catheter ablation on quality of life in patients with atrial flutter. Am J Cardiol 1999, 84: 278–283. 10.1016/S0002-9149(99)00276-3CrossRefPubMed
9.
García Seara J, Gude F, Cabanas P, Martínez Sande JL, Fernández López X, Elices J, Brugada Terradellas J, et al.: Quality of life differences in patients with typical atrial flutter following cavotricuspid isthmus ablation. Rev Esp Cardiol 2011, 64: 401–408. 10.1016/j.recesp.2010.12.014CrossRefPubMed
10.
Saoudi N, Ricard P, Rinaldi JP, Yaïcil K, Darmon JP, Anselme F: Methods to determine bidirectional block of the cavotricuspid isthmus in radiofrequency ablation of typical atrial flutter. J Cardiovasc Electrophysiol 2005, 16: 801–803. 10.1111/j.1540-8167.2005.40624.xCrossRefPubMed
11.
Shah D, Haïssaguerre M, Takahashi A, Jaïs P, Hocini M, Clementy J: Differential pacing for distinguishing block from persistent conduction through an ablation line. Circulation 2000, 102: 1517–1522. 10.1161/01.CIR.102.13.1517CrossRefPubMed
12.
Ware JE Jr, Snow KK, Kosinski M, Gandek B: Scoring the SF-36. In Ware JE Jr. SF-36 Health Survey. Manual & Interpretation Guide. 2nd edition. Boston: The Health Institute, New England Medical Center; 1997:6:1–6:22. 6
13.
Vilagut G, Ferrer M, Rajmil L, Rebollo P, Permanyer G, Quintana J, Santed R, et al.: El cuestionario de salud SF-36 español: una década de experiencia y nuevos desarrollos. Gac Sanit 2005, 19: 135–150. 10.1157/13074369CrossRefPubMed
14.
Vilagut G, Valderas JM, Ferrer M, Garin O, López-García E, Alonso J: Interpretación de los cuestionarios SF-36 y SF-12 en España: componentes físico y mental. Med Clin 2008, 130: 726–735. 10.1157/13121076CrossRef
15.
Gilligan D, Zakaib J, Fuller I, Shepard R, Dan D, Wood M, et al.: Long-term outcome of patients after successful radiofrequency ablation for typical atrial flutter. Pacing Clin Electrophysiol 2003, 26(Pte I):53–58.CrossRefPubMed
16.
Schmieder S, Ndrepepa G, Dong J, Zrenner B, Schreieck J, Schneider AE, Karch M, et al.: Acute and long-term results of radiofrequency ablation of common atrial flutter and the influence of the right atrial isthmus ablation on the ocurrence of atrial fibrillation. Eur Heart J 2003, 24: 956–962. 10.1016/S0195-668X(02)00846-1CrossRefPubMed
17.
Cuesta A, Mont L, Alvarenga N, Rogel U, Brugada J: Comparison of 8-mm-tip and irrigated-tip catheters in the ablation of isthmus-dependent atrial flutter: a prospective randomized trial. Rev Esp Cardiol 2009, 62: 750–756. 10.1016/S0300-8932(09)71688-4CrossRefPubMed
18.
Chen J, De Chillou C, Ohm OJ, Hoff PI, Rossvoll O, Andronache M, Sadoul N, et al.: Acute resumption of conduction in the cavotricuspid isthmus after catheter ablation in patients with common atrial flutter. Europace 2002, 4: 255–263. 10.1053/eupc.2002.0243CrossRefPubMed
19.
Scavée C, Georger F, Jamart J, Mancini I, Collet B, Blommaert D, De Roy L: Is a cooled tip catheter the solution for the ablation of the cavotricuspid isthmus? Pacing Clin Electrophysiol 2003, 26: 328–331. 10.1046/j.1460-9592.2003.00043.xCrossRefPubMed
20.
Anselme F, Saoudi N, Poty H, Douillet, Cribier A: Radiofrequency catheter ablation of common atrial flutter: significance of palpitations and quality of life evaluation in patients with proven isthmus block. Circulation 1999, 99: 534–540. 10.1161/01.CIR.99.4.534CrossRefPubMed
21.
Da Costa A, Romeyer-Bouchard C, Zarqane-Sliman N, Messier M, Samuel B, Kihel A, Faure E, et al.: Impact of first line radiofrequency ablation in patients with lone atrial flutter on the long term risk of subsequent atrial fibrillation. Heart 2005, 91: 97–98. 10.1136/hrt.2003.033308PubMedCentralCrossRefPubMed
22.
Ellis K, Wazni O, Marrouche N, Martin D, Gillinov M, McCarthy P, Saad E, et al.: Incidence of atrial fibrillation post-cavotricuspid isthmus ablation in patients with typical atrial flutter. J Cardiovasc Electrophysiol 2007, 18: 799–802. 10.1111/j.1540-8167.2007.00885.xCrossRefPubMed
23.
Anné W, Willems R, Adriaenssens B, Admas J, Ector H, Heidbüchel H: Long-term symptomatic benefit after radiofrequency catheter ablation for atrial flutter despite a high incidence of post-procedural atrial fibrillation. Acta Cardiol 2006, 61: 75–82. 10.2143/AC.61.1.2005143CrossRefPubMed
24.
Riva S, Tondo C, Carbucicchio C, Galimberti P, Fassini G, Della Bella P: Incidence and clinical significance of transformation of atrial fibrillation to atrial flutter in patients undergoing long-term antiarrhythmic drug treatment. Europace 1999, 1: 242–247. 10.1053/eupc.1999.0048CrossRefPubMed
25.
Bertaglia E, Zoppo F, Bonso A, Proclemer A, Verlato R, Corò L, Mantovan R, et al.: Long term follow up of radiofrequency catheter ablation of atrial flutter: clinical course and predictors of atrial fibrillation occurrence. Heart 2004, 90: 59–63. 10.1136/heart.90.1.59PubMedCentralCrossRefPubMed
26.
Pérez F, Schubert C, Parvez B, Pathak V, Ellenbogen KA, Wood MA: Long-term outcomes after catheter ablation of cavo-tricuspid isthmus dependent atrial flutter: A Meta-Analysis. Circ Arrhythm Electrophysiol 2009, 2: 393–401. 10.1161/CIRCEP.109.871665CrossRefPubMed
27.
Meissner A, Christ M, Maagh P, Borchard R, Bracht MV, Wickenbrock I, Trappe, et al.: Quality of life and occurrence of atrial fibrillation in long-term follow-up of common type atrial flutter ablation: Ablation with irrigated 5 mm tip and convencional 8 mm tip electrodes. Clin Res Cardiol 2007, 96: 1–9. 10.1007/s00392-006-0447-yCrossRef
28.
Chinitz JS, Gerstenfeld EP, Marchilinski FE, Callans DJ: Atrial fibrillation is common after ablation of isolated atrial flutter during long-term follow-up. Hear Rhythm 2007, 4: 1029–1033. 10.1016/j.hrthm.2007.04.002CrossRef
29.
Anastasio N, Frankel D, Deyell M, Zado E, Gerstenfeld E, Dixit S, Cooper J, et al.: Nearly uniform failure of atrial flutter ablation and continuation of antiarrhythmic agents (hybrid therapy) for the long-term control of atrial fibrillation. J Interv Card Electrophysiol 2012.
30.
Laurent V, Fauchier L, Pierre B, Grimard C, Babuty D: Incidence and predictive factors of atrial fibrillation after ablation of typical atrial flutter. J Interv Card Electrophysiol 2009, 24: 119–125. 10.1007/s10840-008-9323-1CrossRefPubMed
31.
Da Costa A, Thêvenin J, Roche F, Romeyer C, Abdellaoui L, Messier M, Denis L, et al.: Results from the Loire-Ardèche-Drôme-Isère-Puy-de-Dôme (LADIP) trial on atrial flutter, a multicentric prospective randomized study comparing amiodarone and radiofrequency ablation after the first episode of symptomatic atrial flutter. Circulation 2006 Oct 17, 114(16):1676–1681. Epub 2006 Oct 9 10.1161/CIRCULATIONAHA.106.638395CrossRefPubMed
32.
Härden M, Nyström B, Kulich K, Carlsson J, Bengtson A, Edvardsson N: Validity and reliability of a new, short symptom rating scale in patients with persistent atrial fibrillation. Health Qual Life Outcomes 2009, 7: 65. 10.1186/1477-7525-7-65PubMedCentralCrossRefPubMed
33.
Badia X, Arribas F, Ormaetxe J, Peinado R, Sainz de los Terreros M: Development of a questionnaire to measure health-related quality of life (HRQoL) in patients with atrial fibrillation (AF-QoL). Health Qual Life Outcomes 2007, 5: 37. 10.1186/1477-7525-5-37PubMedCentralCrossRefPubMed
34.
Eitel C, Husser D, Hindricks G, Frühauf M, Hilbert S, Arya A, et al.: Performance of an implantable automatic atrial fibrillation detection device: impact of software adjustments and relevance of manual episode analysis. Europace 2011, 13: 480–485. 10.1093/europace/euq511PubMedCentralCrossRefPubMed
Metadata
Title
Health-related quality of life in different clinical subgroups with typical AFL who have undergone cavo-tricuspid isthmus ablation
Authors
Javier García Seara
Francisco Gude
Pilar Cabanas
José L Martínez-Sande
Xesús Fernández López
Antonio Hernández Madrid
Concepción Moro
José González Juanatey R
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2012
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/1477-7525-10-90

Other articles of this Issue 1/2012

Health and Quality of Life Outcomes 1/2012 Go to the issue

Research

A cross sectional assessment of health related quality of life among patients with Hepatitis-B in Pakistan

Research

Development of six PROMIS pediatrics proxy-report item banks

Research

Construction of the descriptive system for the assessment of quality of life AQoL-6D utility instrument

Research

The influences of patient's satisfaction with medical service delivery, assessment of medical service, and trust in health delivery system on patient's life satisfaction in China

Research

Quality of life themes in Canadian adults and street youth who are homeless or hard-to-house: A multi-site focus group study

Research

Patients undergoing subacute rehabilitation have accurate expectations of their health-related quality of life at discharge